• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Topas and Lilly sign deal to focus on immune tolerance pharmaceutical-technology
    August 24, 2017
    German biotechnology company Topas Therapeutics has signed a multi-year agreement with Eli Lilly and Company to jointly work on antigen-specific tolerance induction, with an initial focus on external antigens thought to induce inflammation and / or autoim
  • Lilly pens deal for Evotec spinout’s immune tolerance drugs fiercebiotech
    August 23, 2017
    Eli Lilly's headquartersTopas spun out of Evotec last year, picking up €14 million ($16 million) from its parent company and other investors along the way.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service